Eesti - eesti - Ravimiamet

bremer pharma gmbh - tiamiin+riboflaviin+dekspantenool+tsüanokobalamiin+pangaamhape+püridoksiin - süstelahus - 10mg+4mg+2mg+0,01mg+50mg+4mg 1ml 50ml 1tk; 10mg+4mg+2mg+0,01mg+50mg+4mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 268mg+241,2mg 2.68ml 2.68ml 30tk; 268mg+241,2mg 2.68ml 2.68ml 24tk; 268mg+241,2mg 2.68ml 2.68ml 8tk; 268mg+241,2mg 2.68ml 2.68ml 90tk; 268mg+241,2mg 2.68ml 2.68ml 2tk; 268mg+241,2mg 2.68ml 2.68ml 3tk; 268mg+241,2mg 2.68ml 2.68ml 12tk; 268mg+241,2mg 2.68ml 2.68ml 6tk; 268mg+241,2mg 2.68ml 2.68ml 150tk; 268mg+241,2mg 2.68ml 2.68ml 4tk; 268mg+241,2mg 2.68ml 2.68ml 120tk; 268mg+241,2mg 2.68ml 2.68ml 1tk

Eesti - eesti - Ecolab

ecolab deutschland gmbh -

Eesti - eesti - Ravimiamet

huvepharma - tulatromütsiin - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 250ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.